Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Non-Current Deffered Revenue (2021 - 2023)

Envoy Medical's Non-Current Deffered Revenue history spans 3 years, with the latest figure at $10.4 million for Q2 2023.

  • On a quarterly basis, Non-Current Deffered Revenue fell 30.0% to $10.4 million in Q2 2023 year-over-year; TTM through Jun 2023 was $10.4 million, a 30.0% decrease, with the full-year FY2022 number at $10.4 million, down 30.0% from a year prior.
  • Non-Current Deffered Revenue hit $10.4 million in Q2 2023 for Envoy Medical, roughly flat from $10.4 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for COCH hit a ceiling of $14.9 million in Q4 2021 and a floor of $10.4 million in Q3 2022.
  • Historically, Non-Current Deffered Revenue has averaged $12.3 million across 3 years, with a median of $10.4 million in 2022.
  • The widest YoY moves for Non-Current Deffered Revenue: up 30.0% in 2022, down 30.0% in 2022.
  • Tracing COCH's Non-Current Deffered Revenue over 3 years: stood at $14.9 million in 2021, then decreased by 30.0% to $10.4 million in 2022, then changed by 0.0% to $10.4 million in 2023.
  • Business Quant data shows Non-Current Deffered Revenue for COCH at $10.4 million in Q2 2023, $10.4 million in Q1 2023, and $10.4 million in Q4 2022.